| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/13/2001 | WO2001040264A3 Peptide antigens |
| 12/13/2001 | WO2001039800A3 Controlled delivery of antigens |
| 12/13/2001 | WO2001035899A3 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | WO2001004150A3 Neisseria meningitidis compounds and anti-infection applications thereof |
| 12/13/2001 | WO2000029008A9 Hiv-specific t-cell induction |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | WO1999061634A9 Method of producing thy a-strains of vibrio cholerae, such strains and their use |
| 12/13/2001 | US20010051708 Purifying antibody; prepare antibody suspension, mix with water soluble liquid, recover clarified antibody, apply to chromatography column, elute antibody, concentrate antibody |
| 12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | US20010051182 For treatment of human papilloma virus (warts) without medication by inducing dermatitis |
| 12/13/2001 | US20010051163 Providing an impure aqueous solution of pertactin free from pertussis toxin (PT) and filamentous haemagglutinin (FHH), purifying by passing the solution with a particulate ion-exchange medium, subjection to ultrafiltration |
| 12/13/2001 | US20010051161 Cold-adapted equine influenza viruses |
| 12/13/2001 | US20010051159 Enhancing oral tolerance to an antigen associated with an autoimmune disease in a patient suffering from autoimmune disease comprising orally administering an antigen associated with the disease and an interleukin-12 inhibitor |
| 12/13/2001 | US20010051155 Using immunoglobulin binding epitopes |
| 12/13/2001 | US20010051153 Grampositive bacteria; gastrointestinal disorders |
| 12/13/2001 | US20010051147 Eliminating pathogens from circulation system |
| 12/13/2001 | DE10026833A1 Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens A method for identifying compounds for modulating the activity of a tumor suppressor |
| 12/13/2001 | DE10024069A1 Konjugat auf der Basis einer heterobifunktionalen Brückenverbindung, die mit einem Immunmodulator und einer zellerkennenden Einheit substituiert ist Conjugate on the basis of a heterobifunctional bridge connection, which is substituted with an immunomodulator and a cell recognizing unit |
| 12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2707766A1 Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 12/13/2001 | CA2412436A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2412197A1 Powder compositions |
| 12/13/2001 | CA2412026A1 Immunostimulatory rna/dna hybrid molecules |
| 12/13/2001 | CA2411578A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 12/13/2001 | CA2411575A1 Immunostimulatory oligodeoxynucleotides |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | CA2411017A1 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | CA2410510A1 Artificial antigen presenting cells and methods of use thereof |
| 12/13/2001 | CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | CA2410052A1 Delivery systems for bioactive agents |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/13/2001 | CA2409287A1 Hepatitis c virus conjugates |
| 12/13/2001 | CA2409197A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 12/13/2001 | CA2408688A1 Method to induce the th1 immune response |
| 12/13/2001 | CA2398277A1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 12/12/2001 | EP1162272A2 Generation of immune responses to prostate-specific antigen (SPA) |
| 12/12/2001 | EP1162269A1 Novel polypeptide |
| 12/12/2001 | EP1161955A2 Induction of immunological tolerance for graft transplantation by the use of humanized non-depleting anti-cd4 antibodies in combination with specific donor bone marrow cells |
| 12/12/2001 | EP1161954A1 Treatment of T cell mediated autoimmune disorders |
| 12/12/2001 | EP1161953A2 IBDV strain for in OVO administration |
| 12/12/2001 | EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 12/12/2001 | EP1161543A1 Metalloprotease polynucleotides and polypeptides |
| 12/12/2001 | EP1161537A1 Non-spreading pestivirus |
| 12/12/2001 | EP1161531A1 Tumor-associated antigen |
| 12/12/2001 | EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 12/12/2001 | EP1161453A1 Cytokine-binding domain |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161443A2 Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof |
| 12/12/2001 | EP1161440A1 Method for refolding molecules of polypeptides containing ig domains |
| 12/12/2001 | EP1161262A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161259A1 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1161227A2 Microparticles for delivery of nucleic acid |
| 12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
| 12/12/2001 | EP1072272A4 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 12/12/2001 | EP0836480B1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0783586B1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 12/12/2001 | EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/12/2001 | EP0662088B1 Inhibitor of collagen-stimulated platelet aggregation |
| 12/12/2001 | EP0651789B1 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 12/12/2001 | EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods |
| 12/12/2001 | EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326361A Methods for detecting, preventing, and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1326359A Human chorionic gonadotropin vaccines |
| 12/12/2001 | CN1326358A Method of DNA vaccination |
| 12/12/2001 | CN1326351A Use of certain drugs for treating nerve root injury |
| 12/12/2001 | CN1325731A Living toxic-reduced bacteria as vaccine |
| 12/12/2001 | CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment |
| 12/11/2001 | US6329517 Dermatomyositis-specific auto-antigen |
| 12/11/2001 | US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases |
| 12/11/2001 | US6329505 Amino acid sequence of polypeptide that is over-expressed in prostate tissue |
| 12/11/2001 | US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/11/2001 | US6329413 Stable oil-in-water emulsion; anionic or nonionic hydrophilic, water soluble emulsifier; galactoarabinan, polygalactose, or polyarabinose; skin protectant |
| 12/11/2001 | US6329202 Antibodies directed against binding associated epitopes |
| 12/11/2001 | US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy |
| 12/11/2001 | US6329198 Production and use of human nm23 protein and antibodies therefor |
| 12/11/2001 | US6329170 Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof |
| 12/11/2001 | US6329168 A polynucleotide sequences encoding a polypetide; antibiotic screening for streptococcus pneumoniae |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6329001 Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| 12/11/2001 | US6328978 Methods for the treatment of immunologically-mediated skin disorders |
| 12/11/2001 | US6328976 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor |
| 12/11/2001 | US6328975 Recombinant swinepox virus |
| 12/11/2001 | US6328974 Immunogenic compositions that potentiate growth hormone activity |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328972 Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens |